3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
18
Active not recruiting
10
Terminated
2
Suspended
2
Not yet recruiting
1
Enrolling by invitation
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Hematopoietic and Lymphatic System Neoplasm
1
Interventions
pembrolizumab
26
Cisplatin
14
Nivolumab
11
Cyclophosphamide
11
Carboplatin
11
Paclitaxel
9
Docetaxel
9
Radiotherapy, Intensity-Modulated
8
Radiotherapy
8
Magnetic Resonance Spectroscopy
8
Radiosurgery
7
Radiation
7
Fluorouracil
7
Bevacizumab
7
Leucovorin
6
Irinotecan
6
Gemcitabine
6
Doxorubicin
6
venetoclax
5
olaparib
5
enzalutamide
5
Prednisone
5
Pemetrexed
5
Oxaliplatin
5
Metformin
5
Azacitidine
5
fludarabine
4
atezolizumab
4
Taxes
4
Surveys and Questionnaires
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Practice Guidelines as Topic
×
30 days
×
Clear all
NCT06484595
2026-05-18
GUIDE
Fred Hutchinson Cancer Center
Phase NA
Completed
100 enrolled